|
|
|
Insider
Information: |
Fuchs Henry J |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
222,228 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$18,063,061 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
222,228 |
|
|
Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 10 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-02-24 |
4 |
OE |
$26.49 |
$397,350 |
D/D |
15,000 |
143,442 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2018-03-15 |
4 |
D |
$83.57 |
$406,234 |
D/D |
(4,861) |
146,448 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2023-03-15 |
4 |
D |
$87.74 |
$421,064 |
D/D |
(4,799) |
224,187 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2020-03-20 |
4 |
D |
$73.05 |
$426,320 |
D/D |
(5,836) |
139,869 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-11-10 |
4 |
OE |
$21.51 |
$430,200 |
D/D |
20,000 |
96,550 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-11-05 |
4 |
AS |
$46.00 |
$460,000 |
D/D |
(10,000) |
52,277 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2018-03-22 |
4 |
D |
$81.36 |
$472,864 |
D/D |
(5,812) |
156,676 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-03-15 |
4 |
D |
$92.50 |
$473,230 |
D/D |
(5,116) |
120,402 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2018-03-22 |
4/A |
D |
$81.36 |
$474,736 |
D/D |
(5,835) |
156,653 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2007-08-13 |
4 |
S |
$32.00 |
$480,478 |
D/D |
(15,000) |
18,334 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-06-16 |
4 |
OE |
$26.49 |
$484,462 |
D/D |
14,397 |
150,819 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-09-15 |
4 |
OE |
$26.49 |
$507,050 |
D/D |
15,000 |
151,422 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2018-01-02 |
4 |
OE |
$26.49 |
$507,050 |
D/D |
15,000 |
148,976 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2019-03-22 |
4 |
D |
$88.05 |
$513,860 |
D/D |
(5,836) |
130,468 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2019-03-25 |
4 |
AS |
$87.86 |
$521,186 |
D/D |
(5,932) |
124,536 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2007-08-30 |
4 |
OE |
$21.01 |
$525,250 |
D/D |
25,000 |
42,292 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-05-16 |
4 |
OE |
$21.01 |
$525,250 |
D/D |
25,000 |
41,975 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-05-29 |
4 |
OE |
$21.01 |
$525,250 |
D/D |
25,000 |
41,975 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-08-14 |
4 |
OE |
$21.01 |
$525,250 |
D/D |
25,000 |
41,975 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2021-03-15 |
4 |
D |
$78.39 |
$584,789 |
D/D |
(7,460) |
110,855 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2013-05-23 |
4 |
AS |
$67.16 |
$584,981 |
D/D |
(8,710) |
44,364 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2013-07-01 |
4 |
AS |
$60.00 |
$600,000 |
D/D |
(10,000) |
43,266 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-07-02 |
4 |
AS |
$40.00 |
$602,808 |
D/D |
(15,000) |
52,277 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-08-05 |
4 |
AS |
$65.00 |
$650,000 |
D/D |
(10,000) |
76,550 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-02-03 |
4 |
AS |
$67.70 |
$676,966 |
D/D |
(10,000) |
42,350 |
0 |
- |
|
294 Records found
|
|
Page 10 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|